global pharmaceutical company
Issues related to tax reform. Monitoring pharmaceutical issues in the American Health Care Act of 2017, H.R.1628 and Better Care Reconciliation Act of 2017.
Monitoring pharmaceutical issues in the FDA Reauthorization Act of 2017, P.L.115-52.
Issues related to drug pricing and value.
TAX - Taxation/Internal Revenue Code PHA - Pharmacy
1 - SENATE 1 - SENATE
THE SIMMONS & RUSSELL GROUP, LLC
601 Pennsylvania Avenue, NW, South Building, Suite 900, Washington, DC, 20004, US
ROBERT A RUSSELL KYLE SIMMONS ROBERT A RUSSELL KYLE SIMMONS